FDA.gov plays a critical role in delivering official drug information, but its current drug profile pages are fragmented, PDF-heavy, and difficult to navigate. The layout is compliance-first, not user-first leading to delays, confusion, and potential risks for both patients and professionals.
To validate these challenges, I conducted a heuristic evaluation, competitive analysis, and secondary research, leveraging ChatGPT to speed up synthesis and uncover deeper patterns. Here is what I found: